Skip to content
Home/Companies/MedTech/Cavidi

Cavidi

MedTech·Sweden·Exited 2020·Held 2yr
Entry
2018
Hold
2yr
Exit
2020

Who owns Cavidi?

Cavidi is a Swedish MedTech company, formerly owned by Impilo, exited in 2020 (exit via MBO). No current private equity owner is on file.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 1 · 2018 · Buyout

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
MBO
Buyer
Original founders
Exit Year
2020

More from Impilo Investment Pool 1

Other portfolio companies in the same fund.

Euro Accident
Active
FinancialsSweden· 2019
Humana
Active
HealthcareSweden· 2019
TFP Fertility
Exited 2024
HealthcareUK· 2019
to Benefit Street Partners
Immedica
Active
PharmaSweden· 2018
Ferrosan Medical Devices
Exited 2024
MedTechDenmark· 2017
to Kirk Kapital, Lundbeckfonden and ATP
NutraQ
Exited 2021
ConsumerNorway· 2017
to Orkla

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Cavidi?

Cavidi was formerly owned by Impilo, exited in 2020. No current private equity owner is on file.

Who did Cavidi sell to?

Impilo sold Cavidi to Original founders in 2020 (MBO).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue